Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) New England Journal of Medicine 68-week trial of 1,961 adults showed semaglutide 2.4 mg weekly achieved 14.9% mean body weight loss versus 2.4% with placebo, establishing landmark weight management efficacy
Primary oral mucosal melanoma: advocate a wait-and-see policy in the clinically N0 patient.Journal of Oral and Maxillofacial Surgery2012;70:11921198
According to the American Academy of Dermatology, just one sunbed session can increase the risk of developing skin cancer by up to 67 per cent
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
Retatrutide is widely referenced in biochemical and cellular research for controlled experimental studies, valued for its high purity, stability, and reproducible performance in laboratory environments
Scientists found that there was this remarkable molecule in 1906, which now serves as an essential redox carrier